The VEGFR3 specific inhibitor SAR131675 was shown in other studies to reduce tumor growth and metastasis in a number of mouse cancer models including breast, colorectal, prostate and pancreatic cancers and found to be well tolerated [10]. Here, FLT4 is linked to familial pancreatic carcinoma.